Second Sight Reports Q3-2017 Net Sales of $1.6 Million, New $122,500 CMS Rate for Argus II

November 10, 2017: By Jon Swedien

Second SightSecond Sight reported Nov. 2 that its Q3-2017 net sales totaled $1.6 million, compared with $1.2 million in the third quarter of 2016.

The Sylmar, California, developer of the Argus II retinal prosthesis said surgeons implanted 12 systems during the third quarter, compared with 19 in Q2-2017 and 14 in Q3-2016.

The Centers for Medicare and Medicaid Services (CMS) issued a final Medicare outpatient payment rate for 2018 of $122.5 thousand for the Argus II and the associated surgical implantation procedure, the company said. The 2017 reimbursement rate was $150 thousand, and the 2016 rate was $95 thousand.

Second Sight said it anticipates a strong Q4-2017, with more than 20 Argus II surgeries completed or scheduled as of Nov. 2.

For the first three quarters of 2017, Second Sight’s total revenues were $4.9 million compared with $3.3 million for the same period in 2016. This increase was mainly due to a higher number of implants and higher average revenues per implant in 2017 compared with the prior year, Second Sight said.

Need Deeper Analysis? Sign up for Market Scope's monthly newsletter to get in-depth coverage of the ophthalmic market, including quarterly procedure volumes based on survey data and meeting coverage from around the world.

Recent Ophthalmic News

Bausch + Lomb Inks Deal with Express Scripts Expanding Vyzulta Coverage

Melgen Seeks Bond, Appeals Conviction on Charges of Medicare Fraud

Avedro, FDA Agree on Design, Size of First Pivotal Phase III Trial for Epi-on Cross-linking

Iridex Reports 2017 Revenues of $41.6 Million

Bar-Ilan University Announces Nano-Drop Candidate to Correct Refractive Error

Essex Bio-Technology Agrees to Invest $5 Million in MeiraGTx, Developer of Gene Therapies

Clearside Biomedical Announces $85 Million Public Offering

ViewPoint Raises $35 Million for Topical Treatment Candidate for Cataracts, Presbyopia

Okogen Raises $10 Million in Series A Round for Viral Conjunctivitis Candidate

SightLife Surgical Acquires KAMRA Corneal Inlay from AcuFocus

Major Leaguer Tommy Pham Plays Through Keratoconus

Glaukos Reports 2017 Net Sales of $159.3 Million

Imprimis Posts 2017 Revenues of $26.77 Million, a 34 Percent Increase

STAAR’s 2017 Net Sales Total $90.6 Million

US FDA Warns Consumers Not to Use Products from Cantrell Drug Company

IDx’ AI-Based Diagnostics System Meets Endpoints in Pivotal Trial for DR

Aerie Plans to Launch Rhopressa in Q2-2018, Expects 2018 Revenues of $20 Million to $30 Million

Valeant Reports 2017 Revenues of $8.72 Billion, a Decline of 10 Percent

Carl Zeiss Meditec Reports $359.7 Million in Revenues for First Quarter of FY2018, a 5.3 Percent Increase

Ophthotech Partners with UMass to Develop ‘Minigene’ Therapy for Retinal Disease

Coming soon

2018 IOL Report: A Global Market Analysis for 2017 to 2023